Atlas Trials

Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis

Clinical trial NCT05001984 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05001984
Sponsor
Chang Gung Memorial Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Intracranial AtherosclerosisAcute Ischemic StrokeICAS - Intracranial Atherosclerosis
Start date
2021-08-01
Primary completion
2025-04-15
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.